Contemporary practice patterns of transurethral therapies for benign prostate hypertrophy: results of a worldwide survey.
Benign prostatic hypertrophy
Global survey
MIST
Practice patterns
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
26
03
2021
accepted:
10
06
2021
pubmed:
19
6
2021
medline:
19
2
2022
entrez:
18
6
2021
Statut:
ppublish
Résumé
To perform a global survey to identify contemporary practice patterns of transurethral therapies for benign prostatic hypertrophy. A REDCap survey was distributed to the ~ 3500 members of the Endourological Society. Surgeons completed demographic information and then selected the BPH therapies they perform 10 cases/year. There were four categories of BPH therapies: ablation, enucleation, resection/vaporization, and MIST (minimally invasive surgical technique). Within each category, there were subcategories to account for different energy modalities. All statistical analyses were performed using SAS 9.4. A total of 175 surgeons responded to our survey. Prostate resection/vaporization remained the most commonly utilized technique (51.9%, n = 147/283) followed by enucleation (22.6%, n = 64/283). Bipolar TURP (bTURP) was the most common modality for prostate resection (69.4%, n = 102/147). Holmium laser enucleation (HoLEP) was the most common modality for enucleation (46.9%, n = 30/64). Urolift® was performed more often than Rezūm™ (55.9% vs. 44.1%, n = 19/34 vs. 15/34, respectively). Among surgeons performing ablation, country of practice was a significantly associated with length of stay (LOS), p < 0.0001. For surgeons performing enucleation, academic institution and completion of a fellowship were associated with postoperative day (POD) 1 catheter removal (p = 0.0240 and p = 0.020, respectively). In this contemporary, global survey of the Endourology Society, resection/vaporization techniques were the most commonly performed. Rates of MISTs remained relatively low at 12.1%. Academic institution and fellowship status were associated with shorter catheterization times and LOS for certain surgical categories.
Identifiants
pubmed: 34143283
doi: 10.1007/s00345-021-03760-z
pii: 10.1007/s00345-021-03760-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4207-4213Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Parsons JK, Barry MJ, Dahm P (2019) Benign prostatic hyperplasia: surgical management of benign prostatic hyperplasia/lower urinary tract symptoms. AUA Guidelines
Smith RD, Patel A (2011) Transurethral resection of the prostate revisited and updated. Curr Opin Urol 21(1):36–41. https://doi.org/10.1097/MOU.0b013e3283411455
doi: 10.1097/MOU.0b013e3283411455
pubmed: 21099690
Das AK (2019) Techniques and innovative technologies for the treatment of BPH. Can J Urol 4(Suppl 1):1
Gravas S, Cornu JN, Gacci M (2020) EAU Guidelines on Management non-neurogenic male lower urinary tract symptoms (LUTS), including Benign prostatic obstruction (BPO). EAU Guidelines Office
Malaeb BSYX, McBean M, Elliot SP (2012) National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000–2008). Urology 79(5):1111–1117
doi: 10.1016/j.urology.2011.11.084
Sosnowski R, De Nunzio C, Ahyai S et al (2015) Surgical management of benign prostatic obstruction: current practice patterns and attitudes in Europe. Neurourol Urodyn 34(4):395–396. https://doi.org/10.1002/nau.22727
doi: 10.1002/nau.22727
pubmed: 25620532
Christidis D, McGrath S, Perera M, Manning T, Bolton D, Lawrentschuk N (2017) Minimally invasive surgical therapies for benign prostatic hypertrophy: the rise in minimally invasive surgical therapies. Prostate Int 5(2):41–46. https://doi.org/10.1016/j.prnil.2017.01.007
doi: 10.1016/j.prnil.2017.01.007
pubmed: 28593165
pmcid: 5448728
Bhojani N, Bidair M, Zorn KC et al (2019) Aquablation for benign prostatic hyperplasia in large prostates (80–150 cc): 1-year results. Urology 129:1–7. https://doi.org/10.1016/j.urology.2019.04.029
doi: 10.1016/j.urology.2019.04.029
pubmed: 31059728
Gilling P, Barber N, Bidair M et al (2018) WATER: a double-blind, randomized, controlled trial of aquablation® vs transurethral resection of the prostate in benign prostatic hyperplasia. J Urol 199(5):1252–1261. https://doi.org/10.1016/j.juro.2017.12.065
doi: 10.1016/j.juro.2017.12.065
pubmed: 29360529
McNicholas TA (2016) Benign prostatic hyperplasia and new treatment options—a critical appraisal of the UroLift system. Med Devices 9:115–123. https://doi.org/10.2147/MDER.S60780
doi: 10.2147/MDER.S60780
Das AKLJ, Roehrborn CG (2019) Office-based therapies for benign prostatic hyperplasia: a review and update. Can J Urol 26(Supp 1):2–7
pubmed: 31481142
Roehrborn CBJ, Gange SN, Shore ND et al (2017) Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol 24(3):8802–8813
pubmed: 28646935
pmcid: 28646935
DA Kelly DC (2012) Holmium laser enucleation of the prostate technique for benign prostatic hyperplasia. Can J Urol 19(1):6131–6134
pubmed: 22316518
Raber M, Buchholz NNP, Vercesi A et al (2018) Thulium laser enucleation of the prostate (ThuLEP): results, complications, and risk factors in 139 consecutive cases. Arab J Urol 16(4):411–416. https://doi.org/10.1016/j.aju.2018.05.004
doi: 10.1016/j.aju.2018.05.004
pubmed: 30534440
pmcid: 6277267
Enikeev D, Glybochko P, Rapoport L et al (2018) Impact of endoscopic enucleation of the prostate with thulium fiber laser on the erectile function. BMC Urol 8(1):87. https://doi.org/10.1186/s12894-018-0400-1
doi: 10.1186/s12894-018-0400-1
Regenbogen SE, Cain-Nielsen AH, Norton EC, Chen LM, Birkmeyer JD, Skinner JS (2017) Costs and consequences of early hospital discharge after major inpatient surgery in older adults. JAMA Surg 152(5):e170123. https://doi.org/10.1001/jamasurg.2017.0123
doi: 10.1001/jamasurg.2017.0123
pubmed: 28329352
pmcid: 5478875
Magistro G, Weinhold P, Stief CG, Gratzke C (2018) The new kids on the block: prostatic urethral lift (Urolift) and convective water vapor energy ablation (Rezum). Curr Opin Urol 28(3):294–300. https://doi.org/10.1097/MOU.0000000000000502
doi: 10.1097/MOU.0000000000000502
pubmed: 29538166